STAT+: Pharmalittle: We’re reading about another AstraZeneca trial failure, a Novo name change, and more

<iframe
  src="https://statesidedaily.com/embed/cluster/6e054335a1d8405725ec108d61e0315a84a470e1"
  width="100%" height="320"
  style="border:0;max-width:680px"
  loading="lazy"
  title="STAT+: Pharmalittle: We&#8217;re reading about another AstraZeneca trial failure, a Novo name change, and more"></iframe>